Merck launches Herceptin biosimilar in U.S.

Merck launches Herceptin biosimilar in U.S.

Submitted by admin on April 15, 2020 - 10:55am
Source: 
Seeking Alpha
News Tags: 
Merck
Herceptin
Roche
biosimilar
Ontruzant
Headline: 
Merck launches Herceptin biosimilar in U.S.
snippet: 

Merck (NYSE:MRK) commences the U.S. commercial launch of Ontruzant (trastuzumab-dttb), a biosimilar to Roche's (OTCQX:RHHBY) breast cancer med Herceptin.

Do Not Allow Advertisers to Use My Personal information